Literature DB >> 29303020

Risk factors, outcomes and genotypes of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream infection: a three-year retrospective study in a large tertiary hospital in Northern China.

Si-Han Zheng1, Sheng-Ji Cao1, Hui Xu1, Dan Feng1, Li-Ping Wan1, Guang-Jie Wang1, Xiao-Guang Xiao1.   

Abstract

OBJECTIVE: To investigate the independent risk factors, outcomes and genotypes associated with carbapenem-non-susceptible K. pneumoniae bloodstream infections (BSIs) in northern China from 2014 to 2016.
METHODS: Over a three-year period, a total of 289 K. pneumoniae BSI patients were identified. Medical records were extracted to obtain the clinical information. Polymerase chain reactions (PCRs) were performed to analyse the multilocus sequence typing (MLST) types, Klebsiella pneumoniae carbapenemase (KPC) and metallo-β-lactamases (MBL) genes, for replicon typing of the 10 randomly selected carbapenem-non-susceptible K. pneumoniae.
RESULTS: A total of 59 carbapenem-non-susceptible K. pneumoniae strains were identified. Resistance rates to imipenem, meropenem, ertapenem and amikacin were low. Multivariate analyses showed that a central venous catheter odds ratio (OR) of 4.021 (CI 1.002-16.134); mechanical ventilation of 7.587 (2.856-20.156); Pitt bacteraemia score of 1.481 (CI 1.218-1.800); hospitalization prior to culture of 1.026 (CI 1.001-1.053); and some antibiotic use 30 days prior to K. pneumoniae bacteremia, including carbapenem of 9.123 (CI 2.995-27.791), aminoglycoside of 34.079 (2.091-555.396), and tigecycline of 5.065 (CI 1.261-20.339) were associated with carbapenem-non-susceptible K. pneumoniae bacteremia. Sequence type 11 (ST11) was the most predominant MLST type, which accounted for 50% of the isolates. Eighty per cent of the isolates harbored the KPC-2 gene. The overall 28-day mortality rates of carbapenem-non-susceptible and carbapenem-susceptible K. pneumoniae were 54.24% and 19.56%, respectively.
CONCLUSION: Central venous catheter, mechanical ventilation, high Pitt bacteraemia score, hospitalization prior to culture, and prior antibiotic use (carbapenem, aminoglycoside and tigecycline) were identified as independent risk factors for carbapenem-non-susceptible K. pneumoniae BSI, which was mostly caused by KPC-2 in northern China.

Entities:  

Keywords:  APACHE II score; Carbapenem; Klebsiella pneumoniae; Pitt bacteraemia score; Risk factor; Sequence type 11

Mesh:

Substances:

Year:  2018        PMID: 29303020     DOI: 10.1080/23744235.2017.1421772

Source DB:  PubMed          Journal:  Infect Dis (Lond)        ISSN: 2374-4243


  4 in total

1.  Outcomes and Risk Factors of Bloodstream Infections Caused by Carbapenem-Resistant and Non-Carbapenem-Resistant Klebsiella pneumoniae in China.

Authors:  Xiaoxue Liang; Ping Chen; Baoguo Deng; Feng-Hui Sun; Yongqiang Yang; Yanxian Yang; Ruowen He; Mingyang Qin; Yiping Wu; Fan Yang; Guo-Bao Tian; Min Dai
Journal:  Infect Drug Resist       Date:  2022-06-17       Impact factor: 4.177

2.  Impact of carbapenem resistance on mortality in patients infected with Enterobacteriaceae: a systematic review and meta-analysis.

Authors:  Ruyin Zhou; Xiangming Fang; Jinjin Zhang; Xiaodong Zheng; Shuangyue Shangguan; Shibo Chen; Yingbo Shen; Zhihai Liu; Juan Li; Rong Zhang; Jianzhong Shen; Timothy R Walsh; Yang Wang
Journal:  BMJ Open       Date:  2021-12-14       Impact factor: 2.692

3.  Comparison of Risk Factors and Outcomes in Carbapenem-Resistant and Carbapenem-Susceptible Gram-Negative Bacteremia.

Authors:  Sinan Cetin; Ilyas Dokmetas; Aziz Ahmad Hamidi; Banu Bayraktar; Alper Gunduz; Dilek Yildiz Sevgi
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2021-09-24

4.  Determination of multidrug-resistant populations and molecular characterization of complex Klebsiella spp. in wild animals by multilocus sequence typing.

Authors:  Alessandra Tammy Hayakawa Ito de Sousa; Marco Túlio Dos Santos Costa; Stefhano Luis Cândido; Herica Makino; Thais Oliveira Morgado; Lucas Avelino Dandolini Pavelegini; Edson Moleta Colodel; Luciano Nakazato; Valéria Dutra
Journal:  Vet World       Date:  2022-07-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.